Skip to main content
Close

Genitourinary

Protocols

Bladder


GUAJPG

Adjuvant therapy for urothelial carcinoma using CISplatin and gemcitabine


GUAVPG

Palliative therapy for urothelial carcinoma using CISplatin and gemcitabine


GUBCG

Therapy for high risk superficial transitional cell bladder cancer using BCG


GUBCGIFN

Palliative Therapy for BCG-Refractory Superficial High-Grade Transitional Cell Carcinoma Bladder with BCG and Interferon


GUBCV

Therapy for transitional cell cancers using CARBOplatin-vinBLAstine


GUBMITO

Intravesical Therapy for Superficial Transitional Cell Bladder Cancer using Mitomycin


GUBPWRT

Treatment of Locally Advanced Bladder Cancer with Weekly CISplatin and Concurrent Radiation


GUMVAC

Therapy for transitional cell cancers of the urothelium using Methotrexate, vinBLAstine, DOXOrubicin and CISplatin


GUNAJPG

Neo-Adjuvant Therapy for Urothelial Carcinoma Using CISplatin and Gemcitabine

Prostate

GUEMCYT

Therapy for androgen-independent prostate cancer using estramustine phosphate


UGUPABI

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Abiraterone and predniSONE


UGUPCABA

Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Cabazitaxel and predniSONE


GUPDOC

Palliative Therapy for Metastatic Hormone Refractory Prostate Cancer Using DOCEtaxel and predniSONE


GUPDOCADT

  • First-Line Treatment of Castration Sensitive, Metastatic Prostate Cancer Using DOCEtaxel and Androgen Deprivation Therapy 

  • UGUPENZ

    Palliative Therapy for Metastatic Castration Resistant Prostate Cancer Using Enzalutamide


    GUPLHRH

    Therapy for Prostate Cancer Using LHRH agonist (Goserelin, Leuprolide or Buserelin)


    GUPLHRHA

    Therapy for Advanced Prostate Cancer Using LHRH antagonist Degarelix


    GUPMX

    Palliative therapy for hormone-refractory prostate cancer using mitoXANTRONE and predniSONE


    GUPNSAA

    Non-Steroidal Treatment of Prostate Cancer


    UGUPRAD

    Therapy for Metastatic Castration Resistant Prostate Cancer Using Radium-223

    Testicular

    GUBEP

    CurativeTherapy for germ cell cancer usingBleomycin, Etoposide and CISplatin


    GUEP

    Therapy for nonseminoma germ cell cancer using Etoposide-CISplatin


    GUSCARB

    Adjuvant therapy for stage I high risk seminoma using CARBOplatin


    UGUTAXGEM

    Palliative therapy for germ cell cancers using PACLitaxel and gemcitabine


    UGUTIP

    Therapy for Relapsed Testicular Germ Cell cancer using PACLitaxel, lfosfamide and CISplatin (TIP)


    GUVEIP

    Consolidation/ Salvage Treatment for Germ Cell Cancer Using VinBLAstine, CISplatin, Ifosfamide and Mesna


    GUVIP2

    Nonseminoma Consolidation/Salvage Protocol using Etoposide, CISplatin, Ifosfamide and Mesna

    Renal/Kidney

    UGUAVNIV

    Treatment of Metastatic or Advanced Renal Cell Carcinoma Using Nivolumab

    UGUAXIT

    Therapy for Metastatic Renal Cell Carcinoma Using Axitinib


    GUEVER

    Therapy for Advanced Renal Cancer Using Everolimus


    GUKIFN

    Therapy for advanced renal cell carcinoma using alpha-Interferon (a-IFN)


    UGUPAZO

    Palliative Therapy for Renal Cell Carcinoma Using Pazopanib


    UGUSORAF

    Palliative Therapy for Renal Cell Carcinoma Using SORAfenib


    UGUSUNI

    Palliative Therapy for Renal Cell Carcinoma Using SUNItinib


    UGUTEM

    Therapy for Advanced Renal Cancer Using Temsirolimus

    Miscellaneous

    GUAVD

    Palliative Therapy for Advanced Adrenal Cortical Cancer Using DOXOrubicin


    GUEDPM

    Treatment of Metastatic Adrenocortical Cancer with Etoposide, DOXOrubicin, CISplatin and Mitotane


    GUFUPRT

    Combined Modality Therapy for Squamous Cell Cancer of the Genitourinary System Using Fluorouracil and CISplatin with Radiation


    GUMITO

    Treatment of Adrenal Cortical Cancer with Mitotane


    GUSCPE

    Palliative Therapy of Extensive Stage Genitourinary Small Cell Tumours with a Platinum and Etoposide


    GUSCPERT

    Therapy of Genitourinary Small Cell Tumors with a Platin and Etoposide with Radiation

    Terms of use

    The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

    Use of these documents is at your own risk and is subject to the BC Cancer Agency's Terms of Use.
    Tab Heading
    Tab Heading
    SOURCE: Genitourinary ( )
    Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

    Copyright © BC Cancer Agency. All Rights Reserved.

      Copyright © 2017 Provincial Health Services Authority